Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial

Condition:   Multidrug Resistant Tuberculosis Interventions:   Drug: Bedaquiline;   Drug: Pretomanid;   Drug: Moxifloxacin;   Drug: Linezolid;   Drug: Clofazimine;   Drug: Directly observed therapy (DOT) Sponsors:   Medecins Sans Frontieres, Netherlands;   University of Sussex;   London School of Hygiene and Tropical Medicine;   Doris Goodwin Hospitals, Kwazulu Natal, South Africa;   Don McKenzie Hospitals, Kwazulu Natal, South Africa;   Republican Scientific and Practical Centre for Pulmono logy and Tuberculosis hospital;   Republican specialised scientific-practical medical centre, Tashkent;   Republican TB Hospital No. 2, Nukus Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials